|
1
|
Smith RA, Andrews KS, Brooks D, Fedewa SA,
Manassaram-Baptiste D, Saslow D, Brawley OW and Wender RC: Cancer
screening in the United States, 2017: A review of current american
cancer society guidelines and current issues in cancer screening.
CA Cancer J Clin. 67:100–121. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
By the numbers: Cancer mortality,
2011–2015. Cancer Discov. 8:9072018.
|
|
3
|
de Groot PM, Wu CC, Carter BW and Munden
RF: The epidemiology of lung cancer. Transl Lung Cancer Res.
7:220–233. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rybarczyk-Kasiuchnicz A and Ramlau R:
Current views on molecularly targeted therapy for lung cancer-a
review of literature from the last five years. Kardiochir
Torakochirurgia Pol. 15:119–124. 2018.PubMed/NCBI
|
|
5
|
Varol M, Koparal AT, Benkli K and
Bostancioglu RB: Anti-lung cancer and anti-angiogenic activities of
new designed boronated phenylalanine metal complexes. Curr Drug
Deliv. Jul 27–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miura Y and Sunaga N: Role of
immunotherapy for oncogene-driven non-small cell lung cancer.
Cancers (Basel). 10:E2452018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen CY, Chen J, He L and Stiles BL: PTEN:
Tumor suppressor and metabolic regulator. Front Endocrinol
(Lausanne). 9:3382010. View Article : Google Scholar
|
|
9
|
Jamaspishvili T, Berman DM, Ross AE, Scher
HI, De Marzo AM, Squire JA and Lotan TL: Clinical implications of
PTEN loss in prostate cancer. Nat Rev Urol. 15:222–234. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee YR, Chen M and Pandolfi PP: The
functions and regulation of the PTEN tumour suppressor: New modes
and prospects. Nat Rev Mol Cell Biol. 19:547–562. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kong Y, Yin J, Fu Y, Chen Y, Zhou Y and
Geng X: Suppression of Elk1 inhibits thyroid cancer progression by
mediating PTEN expression. Oncol Rep. 40:1769–1776. 2018.PubMed/NCBI
|
|
12
|
Tian DD, Zhang RX, Wu N, Yuan W, Luo SH,
Chen HQ, Liu Y, Wang Y, He BC and Deng ZL: Tetrandrine inhibits the
proliferation of human osteosarcoma cells by upregulating the PTEN
pathway. Oncol Rep. 37:2795–2802. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiong J, Li Z, Zhang Y, Li D, Zhang G, Luo
X, Jie Z, Liu Y, Cao Y, Le Z, et al: PRL-3 promotes the peritoneal
metastasis of gastric cancer through the PI3K/Akt signaling pathway
by regulating PTEN. Oncol Rep. 36:1819–1828. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Yang C, Zhou F and Chen X: PDK1
inhibitor GSK2334470 synergizes with proteasome inhibitor MG132 in
multiple myeloma cells by inhibiting full AKT activity and
increasing nuclear accumulation of the PTEN protein. Oncol Rep.
39:2951–2959. 2018.PubMed/NCBI
|
|
15
|
Zhao Y, Zheng R, Li J, Lin F and Liu L:
Loss of phosphatase and tensin homolog expression correlates with
clinicopathological features of non-small cell lung cancer patients
and its impact on survival: A systematic review and meta-analysis.
Thorac Cancer. 8:203–213. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu X, Li Z, Li T, Long F, Lv Y, Liu L,
Liu X and Zhan Q: Osthole inhibits the PI3K/AKT signaling pathway
via activation of PTEN and induces cell cycle arrest and apoptosis
in esophageal squamous cell carcinoma. Biomed Pharmacother.
102:502–509. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lim SL, Goh YM, Noordin MM, Rahman HS,
Othman HH, Bakar Abu NA and Mohamed S: Morinda citrifolia edible
leaf extract enhanced immune response against lung cancer. Food
Funct. 7:741–751. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang C, Cheng Y, Liu H, Xu Y, Peng H, Lang
J, Liao J, Liu H, Liu H and Fan J: Pectolinarigenin suppresses the
tumor growth in nasopharyngeal carcinoma. Cell Physiol Biochem.
39:1795–1803. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang T, Li S, Li J, Yin F, Hua Y, Wang Z,
Lin B, Wang H, Zou D, Zhou Z, et al: Natural product
pectolinarigenin inhibits osteosarcoma growth and metastasis via
SHP-1-mediated STAT3 signaling inhibition. Cell Death Dis.
7:e24212016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu C, Wang H, Chen S, Yang R, Li H and
Zhang G: Baicalein inhibits cell growth and increases cisplatin
sensitivity of A549 and H460 cells via miR-424-3p and targeting
PTEN/PI3K/Akt pathway. J Cell Mol Med. 22:2478–2487. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu C, Zhang B, Li YL and Yu XR: SIX1
reduces the expression of PTEN via activating PI3K/AKT signal to
promote cell proliferation and tumorigenesis in osteosarcoma.
Biomed Pharmacother. 105:10–17. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Z, Hong S and Liu Z: LncRNA LINC00641
predicts prognosis and inhibits bladder cancer progression through
miR-197-3p/KLF10/PTEN/PI3K/AKT cascade. Biochem Biophys Res Commun.
503:1825–1829. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu J, Xing Y and Rong L: miR-181
regulates cisplatin-resistant non-small cell lung cancer via
downregulation of autophagy through the PTEN/PI3K/AKT pathway.
Oncol Rep. 39:1631–1639. 2018.PubMed/NCBI
|
|
25
|
Jing X, Cheng W, Wang S, Li P and He L:
Resveratrol induces cell cycle arrest in human gastric cancer
MGC803 cells via the PTEN-regulated PI3K/Akt signaling pathway.
Oncol Rep. 35:472–478. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Matsuda S, Nakagawa Y, Kitagishi Y,
Nakanishi A and Murai T: Reactive oxygen species, superoxide
dimutases, and PTEN-p53-AKT-MDM2 signaling loop network in
mesenchymal stem/stromal cells regulation. Cells. 7:E362018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Assis LV and Isoldi MC: The function,
mechanisms, and role of the genes PTEN and TP53 and the effects of
asbestos in the development of malignant mesothelioma: A review
focused on the genes' molecular mechanisms. Tumour Biol.
35:889–901. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He M, Jiang L, Li B, Wang G, Wang J and Fu
Y: Oxymatrine suppresses the growth and invasion of MG63 cells by
up-regulating PTEN and promoting its nuclear translocation.
Oncotarget. 8:65100–65110. 2017.PubMed/NCBI
|
|
29
|
Oxnard GR, Hu Y, Mileham KF, Husain H,
Costa DB, Tracy P, Feeney N, Sholl LM, Dahlberg SE, Redig AJ, et
al: Assessment of resistance mechanisms and clinical implications
in patients with EGFR T790m-positive lung cancer and acquired
resistance to osimertinib. JAMA Oncol. Aug 2–2018.(Epub ahead of
print). View Article : Google Scholar
|
|
30
|
Dai Z, Wang L, Wang X, Zhao B, Zhao W,
Bhardwaj SS, Ye J, Yin Z, Zhang J and Zhao S: Oxymatrine induces
cell cycle arrest and apoptosis and suppresses the invasion of
human glioblastoma cells through the EGFR/PI3K/Akt/mTOR signaling
pathway and STAT3. Oncol Rep. 40:867–876. 2018.PubMed/NCBI
|
|
31
|
Li W, Yu X, Ma X, Xie L, Xia Z, Liu L, Yu
X, Wang J, Zhou H, Zhou X, et al: Deguelin attenuates non-small
cell lung cancer cell metastasis through inhibiting the CtsZ/FAK
signaling pathway. Cell Signal. 50:131–141. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Koundouros N and Poulogiannis G:
Phosphoinositide 3-kinase/Akt signaling and redox metabolism in
cancer. Front Oncol. 8:1602018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liao K, Yong CW and Hua K: SB431542
inhibited cigarette smoke extract induced invasiveness of A549
cells via the TGF-β1/Smad2/MMP3 pathway. Oncol Lett. 15:9681–9686.
2018.PubMed/NCBI
|
|
34
|
Wu C, Zhu X, Liu W, Ruan T, Wan W and Tao
K: NFIB promotes cell growth, aggressiveness, metastasis and EMT of
gastric cancer through the Akt/Stat3 signaling pathway. Oncol Rep.
40:1565–1573. 2018.PubMed/NCBI
|
|
35
|
Xing Y, Liu Y, Liu T, Meng Q, Lu H, Liu W,
Hu J, Li C, Cao M, Yan S, et al: TNFAIP8 promotes the proliferation
and cisplatin chemoresistance of non-small cell lung cancer through
MDM2/p53 pathway. Cell Commun Signal. 16:432018. View Article : Google Scholar : PubMed/NCBI
|
